Researchers at the Shibaura Institute of Technology (SIT) in Japan have developed a novel vitamin K analogue that demonstrates significantly…
Read More
UCB Acquires Neurona Therapeutics for Up to $1.15 Billion to Bolster Epilepsy Pipeline with Regenerative Cell Therapy
BRUSSELS, BELGIUM & SAN FRANCISCO, USA – April 20, 2026 – Global biopharmaceutical leader UCB has finalized a definitive agreement…
Read More
Molecular Switch FLI-1 Identified as Key Regulator for Blood Stem Cell Activation and Enhanced Regenerative Medicine Outcomes
The biological mechanisms governing the transition of blood stem cells from a dormant state to an active, regenerative phase have…
Read More
Molecular Switch FLI-1 Identified as Essential Regulator for Blood Stem Cell Activation and Enhanced Regenerative Medicine
In a significant advancement for the field of hematology and regenerative medicine, researchers at Weill Cornell Medicine have identified a…
Read More
